circadian clock is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-01-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also marketed informally as Stenabolic |
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ |
| Molecular formula | C24H30ClN3O4S | Approximate molecular weight 492 g/mol |
| CAS Registry Number | 1379686-30-2 | Identifier for the parent compound |
| Regulatory status | Not approved for human use | Prohibited in sport by WADA |
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
=== Emergency preparation === Guides for surviving emergency conditions in many parts of the world recommend maintaining a store of essential foods. A food storage calculator can help determine how much of these staple foods a person needs to store to sustain life for one full year. In addition to storing basic food items, many people choose to supplement their food storage with frozen or preserved garden-grown fruits and vegetables, as well as freeze-dried or canned produce. An unvarying diet of staple foods prepared in the same manner can cause appetite exhaustion, leading to less caloric intake. Another benefit of having a basic supply of food stored in the home is the potential for cost savings. Costs of dry bulk foods (before preparation) are often considerably less than convenience and fresh foods purchased at local markets or supermarkets. There is a significant market in convenience foods for campers, such as dehydrated food products.
A separate consequence is that the freshly milled particles carry high surface energy and acquire substantial triboelectric charge by repeated particle–wall and particle–particle contact during milling and downstream handling. The resulting electrostatic forces drive agglomeration, complicate blending uniformity, and — in dry powder inhaler formulations — cause drift in fine-particle fraction during storage as the powder relaxes toward thermodynamic equilibrium. To mitigate these effects, micronized actives intended for high-sensitivity applications are commonly subjected to a post-milling conditioning step, in which the powder is exposed to controlled humidity or a solvent vapour for hours to days to allow surface relaxation, partial recrystallization, and reduction of stored mechanical energy before formulation. Mechanical micronization is generally unsuitable for biologic APIs such as proteins, because the high-energy stresses of jet milling can cause denaturation; spray drying with stabilizing excipients is the route typically used to produce inhalable dry powders of biologics.
==== 2026 ==== Scientists at the University of New Mexico reported that the enzyme OTULIN, known for regulating immune activity, plays a major role in producing Tau proteins, which are associated with neurodegenerative disorders including Alzheimer's disease, brain inflammation, and aging. The research team found that disabling OTULIN stopped Tau production and removed existing Tau from neurons. A study at the Weizmann Institute of Science suggested that genetics play a larger role in determining human lifespan than previously believed, estimating that longevity is 50% heritable, about double what previous studies had concluded and matching the findings of lifespan studies in animals. A research team led by Johannes Gräff at EPFL found that partial reprogramming of engram neurons reversed cognitive decline in aged mice as well as mice with Alzheimer's. Scientists at the University of Rochester successfully transferred a longevity-related gene from naked mole rats to mice, which made the mice healthier and extended their lifespans. A study at the University of Sydney reported that a four-week diet change in older adults, with reduced fat intake or shift to plant-based protein, improved key health biomarkers tied to aging, with a low-fat and high-carb diet giving the strongest results. A study at the University of Texas Medical Branch found that transplanting a youthful gut microbiome into aging mice reversed aging in the liver and prevented liver cancer.
Human serum albumin is the main protein of human blood plasma. It makes up around 50% of human plasma proteins. It binds water, cations (such as Ca2+, Na+ and K+), fatty acids, hormones, bilirubin, thyroxine (T4) and pharmaceuticals (including barbiturates). Its main function is to regulate the oncotic pressure of blood. The isoelectric point of albumin is 4.7. Alpha-fetoprotein is a fetal plasma protein that binds various cations, fatty acids and bilirubin. Vitamin D-binding protein binds to vitamin D and its metabolites, as well as to fatty acids. Afamin binds vitamin E. It seems to carry lipidated Wnt proteins and Vitamin E around. Extracellular matrix protein 1 is a less canonical albumin. It regulates bone mineralization. The four canonical human albumins are arranged on chromosome 4 region 4q13.3 in a tandem manner.
Sources: en.wikipedia.org
As Russia regained stability, discontent grew within the serf and peasant populations. Under Alexis Romanov, Mikhail's son, the Code of 1649 divided the Russian population into distinct and fixed hereditary categories. The Code increased tax revenue for the central government and put an end to nomadism, to stabilize the social order by fixing people on the same land and in the same occupation as their families. Peasants were tied to the land, and townsmen were forced to take on their fathers' occupations. The increased tax burden fell mainly on the peasants, further widening the gap between the poor and wealthy. Human and material resources became limited as the government organized more military expeditions, putting even greater strain on the peasants. War with Poland and Sweden in 1662 led to a fiscal crisis, and rioting across the country. Taxes, harsh conditions, and the gap between social classes drove peasants and serfs to flee. Many went to the Cossacks, knowing that the Cossacks would accept refugees and free them. The Cossacks experienced difficulties under Tsar Alexis as more refugees arrived daily. The Tsar gave the Cossacks a subsidy of food, money, and military supplies in return for acting as border defense. These subsidies fluctuated often; a source of conflict between the Cossacks and the government. The war with Poland diverted necessary food and military shipments to the Cossacks as fugitive peasants swelled the population of the Cossack host.
There are many thousands of variants of SARS-CoV-2, which can be grouped into the much larger clades. Several different clade nomenclatures have been proposed. Nextstrain divides the variants into five clades (19A, 19B, 20A, 20B, and 20C), while GISAID divides them into seven (L, O, V, S, G, GH, and GR). Several notable variants of SARS-CoV-2 emerged in late 2020. The World Health Organization has currently declared five variants of concern, which are as follows:
== Prognosis == IRIS has a reported mortality rate of 4.5%. Mortality rates vary and depend on the associated OI, degree of immunosuppression, geography, and access to treatment. IRIS affecting the central nervous system has generally been associated with the highest mortality rates (13-75%).
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.
No. SR9009 has not been approved as a therapeutic drug in the United States, European Union, or other major markets. Human safety and efficacy data are very limited. Its presence in consumer products does not imply regulatory approval.
The World Anti-Doping Agency lists SR9009 as a prohibited substance because it can alter gene expression and metabolic pathways relevant to performance. The ban applies at all times, not only during competition. Detection relies on laboratory methods such as mass spectrometry.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.